Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes
Open Access
- 2 August 2023
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 183, 107318
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robustJournal of Clinical Epidemiology, 2016
- A review of the management of elderly patients with non-small-cell lung cancerAnnals of Oncology, 2015
- Defining "elderly" in clinical practice guidelines for pharmacotherapyPharmacy Practice, 2014
- End Points and Trial Design in Geriatric Oncology Research: A Joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology Position ArticleJournal of Clinical Oncology, 2013
- EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumorsAnnals of Oncology, 2011
- Geriatric oncology research in the cooperative groups: A report of a SIOG special meetingJournal of Geriatric Oncology, 2010
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly StudyJournal of Clinical Oncology, 2005
- Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer Symptom Scale (LCSS)European Journal of Cancer, 1993